Literature DB >> 25434944

To fractionate or not to fractionate? That is the question for the radiosurgery of hypoxic tumors.

Iuliana Toma-Dasu1, Helena Sandström, Pierre Barsoum, Alexandru Dasu.   

Abstract

OBJECT: This study aimed to investigate the impact of tumor hypoxia on treatment outcome for metastases commonly treated with radiosurgery using 1 fraction of radiation and the potential gain from reoxygenation if the treatment is delivered in a few radiation fractions.
METHODS: In silico metastasis-like radiosurgery targets were modeled with respect to size, density of clonogenic cells, and oxygenation. Treatment plans were produced for the targets using Leksell GammaPlan, delivering clinically relevant doses and evaluating the tumor control probability (TCP) that could be expected in each case. Fractionated schedules with 3, 4, and 5 fractions resulting in similar biological effective doses were also considered for the larger target, and TCP was determined under the assumption that local reoxygenation takes place between fractions.
RESULTS: The results showed that well-oxygenated small- and medium-size metastases are well controlled by radiosurgery treatments delivering 20 or 22 Gy at the periphery, with TCPs ranging from 90% to 100%. If they are moderately hypoxic, the TCP could decrease to 60%. For large metastases, the TCPs from single-fraction treatments ranged from 0% to 19%, depending on tumor oxygenation. However, for fractionated treatments, the TCP for hypoxic tumors could significantly increase up to 51%, if reoxygenation occurs between fractions.
CONCLUSIONS: This study shows that hypoxia worsens the response to single-fraction radiosurgery, especially for large tumors. However, fractionated therapy for large hypoxic tumors might considerably improve the TCP and might constitute a simple way to improve the outcome of radiosurgery for patients with hypoxic tumors.

Entities:  

Keywords:  BED = biological effective dose; HF = hypoxic fraction; HI = heterogeneity index; TCP = tumor control probability; fractionation; metastases; radiosurgery; stereotactic radiosurgery; tumor hypoxia

Mesh:

Year:  2014        PMID: 25434944     DOI: 10.3171/2014.8.GKS141461

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

1.  Postoperative local fractionated radiotherapy for resected single brain metastases.

Authors:  Ahmad Walid Ayas; Stefan Grau; Karolina Jablonska; Daniel Ruess; Maximilian Ruge; Simone Marnitz; Roland Goldbrunner; Martin Kocher
Journal:  Strahlenther Onkol       Date:  2018-09-14       Impact factor: 3.621

2.  Multisession gamma knife surgery for large brain metastases.

Authors:  Toshinori Hasegawa; Takenori Kato; Takashi Yamamoto; Hiroshi Iizuka; Tomohide Nishikawa; Hiroshi Ito; Naoki Kato
Journal:  J Neurooncol       Date:  2016-11-10       Impact factor: 4.130

Review 3.  Charged-particle therapy in cancer: clinical uses and future perspectives.

Authors:  Marco Durante; Roberto Orecchia; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

4.  Radiation-induced Vascular Damage and the Impact on the Treatment Outcome of Stereotactic Body Radiotherapy.

Authors:  Emely Kjellsson Lindblom; Susanta Hui; Jamison Brooks; Alexandru Dasu; Maciej Kujawski; Iuliana Toma-Dasu
Journal:  Anticancer Res       Date:  2019-06       Impact factor: 2.480

5.  Physics and biomedical challenges of cancer therapy with accelerated heavy ions.

Authors:  Marco Durante; Jürgen Debus; Jay S Loeffler
Journal:  Nat Rev Phys       Date:  2021-09-17

6.  Comparison of Volumetric Modulated Arc Therapy and Intensity Modulated Radiation Therapy for Whole Brain Hippocampal Sparing Treatment Plans Based on Radiobiological Modeling.

Authors:  Ethan Kendall; Ozer Algan; Salahuddin Ahmad
Journal:  J Med Phys       Date:  2018 Jan-Mar

7.  Annealing-modulated nanoscintillators for nonconventional X-ray activation of comprehensive photodynamic effects in deep cancer theranostics.

Authors:  Yao-Chen Chuang; Chia-Hui Chu; Shih-Hsun Cheng; Lun-De Liao; Tsung-Sheng Chu; Nai-Tzu Chen; Arthur Paldino; Yu Hsia; Chin-Tu Chen; Leu-Wei Lo
Journal:  Theranostics       Date:  2020-05-20       Impact factor: 11.556

Review 8.  Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases.

Authors:  Enrique Gutiérrez; Irving Sánchez; Omar Díaz; Adrián Valles; Ricardo Balderrama; Jesús Fuentes; Brenda Lara; Cipatli Olimón; Víctor Ruiz; José Rodríguez; Luis H Bayardo; Matthew Chan; Conrad J Villafuerte; Jerusha Padayachee; Alexander Sun
Journal:  Curr Oncol       Date:  2021-07-15       Impact factor: 3.677

Review 9.  Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy.

Authors:  Ying-Chieh Yang; Chi-Shiun Chiang
Journal:  Front Oncol       Date:  2016-06-30       Impact factor: 6.244

10.  Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study.

Authors:  Jaap D Zindler; Jacqueline Schiffelers; Philippe Lambin; Aswin L Hoffmann
Journal:  Strahlenther Onkol       Date:  2018-01-18       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.